Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01385982 · ClinicalTrials.gov registry record · Phase 3
Improving Management of Outpatient Actionable Test Results
A Phase 3 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 6,000
- Enrollment target
NCT01385982 is a Phase 3 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 6,000 participants.
The verdict
NCT01385982, a Phase 3 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 6,000 participants
- Enrollment target
Study Summary
Clinically significant test results require timely clinician follow-up including the non-urgent clinically significant, or actionable, test results that have received less standardized management and attention. Unfortunately, failure to correctly manage actionable test results is not infrequent and may be associated with important delays in diagnosis and treatment and patient harm. The investigators have designed a safe practice intervention to improve the management of actionable test results for ambulatory patients in a large healthcare system.
Interventions
- OTHER Actionable Test Result Management/Standardization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,000 participants |
| Start Date | 2011-07 |
| Est. Completion | 2013-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01385982
The ClinicalTrials.gov registry entry for NCT01385982 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 6,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Actionable Test Result Management/Standardization is the first listed.
NCT01385982 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01385982 about?
NCT01385982 is a clinical study titled "Improving Management of Outpatient Actionable Test Results". Clinically significant test results require timely clinician follow-up including the non-urgent clinically significant, or actionable, test results that have received less standardized management and attention. Unfortunately, failure to correctly manage actionable test results is not infrequent and ...
What is the current status of trial NCT01385982?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 6,000 participants. The study started on 2011-07. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01385982?
The interventions under investigation include: Actionable Test Result Management/Standardization (OTHER).
Who is sponsoring clinical trial NCT01385982?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.